Taylor Morrison Home Corporation stocks have been trading up by 22.42 percent amid upbeat housing demand and strong earnings momentum
Click Here for a Millionaire's POV on Trading TMHC
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Berkshire Hathaway is buying Taylor Morrison for $72.50 per share in cash, a 24% premium to the prior close and an equity value near $6.8B with an $8.5B enterprise value.
- The TMHC acquisition is expected to close in 2H 2026, pending shareholder approval and standard regulatory reviews.
- Once the Berkshire deal closes, TMHC will be taken private and the stock will be delisted, ending its run as a public trading vehicle.
- The homebuilder has earned a second straight Great Place To Work certification, underscoring strong culture and high employee satisfaction during this transition.
Live Update At 12:32:41 EDT: On Monday, June 01, 2026 Taylor Morrison Home Corporation stock [NYSE: TMHC] is trending up by 22.42%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
TMHC just went from a typical cyclical homebuilder trade to a classic merger-arb story. Before the Berkshire Hathaway deal, Taylor Morrison Home Corporation was already putting up solid numbers. Revenue over the last year ran about $8.1B, with a healthy 22.3% gross margin and an EBIT margin of 12.6%. For a builder, those are strong, disciplined results, not boom-or-bust chaos.
Net income in the latest reported quarter came in around $98.6M, translating to diluted EPS of $1.01. On that base, TMHC had been trading at a modest price/earnings ratio of 8.73 — a discount to many quality names in housing. Return on capital above 29% and return on assets near 9% show that Taylor Morrison squeezes real performance out of its land, lots, and projects.
More Breaking News
- HKIT Stock Explodes Higher As Traders Pile Into Volatility
- Nebius Group NBIS Stock Surges On Profit Swing And AI Hype
- MNKD Rises As MannKind Targets Needle-Free Pediatric Insulin Breakthrough
- Nebius Group NBIS Stock Jumps On Profit Shock And AI Bet
The balance sheet is not reckless. TMHC reported about $653M in cash against total assets just under $9.8B, plus interest coverage of 17.3 times. Short-term liquidity looks manageable with a current ratio of 1.2. For traders, the key is that these fundamentals are now mostly background. With an agreed takeout price above the market, TMHC’s chart is locking onto that $72.50 anchor.
Why Traders Are Watching TMHC After The Berkshire Deal
TMHC has become one of those textbook moments you want to study if you trade news and mergers. The stock was grinding higher in May, closing at $59.47 on 2026/05/07 and riding steady uptrends into the high-$50s. Then the Berkshire Hathaway acquisition hit. Suddenly, TMHC jumped to the low-$70s and pinned near $71.61 on 2026/06/01, right below the $72.50 cash offer.
Look at the intraday action. The 5‑minute chart shows TMHC trading in an ultra-tight band, mostly between $71.55 and $71.70. That is classic arbitrage behavior. The market is now pricing Taylor Morrison as “cash plus deal risk,” not as a normal homebuilding cycle trade. Volatility collapses, volume can stay heavy, and the edge shifts from trend following to spread analysis.
For short-term traders, the game changes. Upside is capped near $72.50 unless another bidder shows up or Berkshire sweetens the pot. Downside is tied to deal risk — shareholder rejection, regulatory headaches, or macro shocks before 2H 2026. TMHC becomes less about earnings beats and more about probabilities and timelines.
At the same time, Berkshire’s willingness to pay a 24% premium sends a clear message about what Taylor Morrison is worth to a long‑term owner. A roughly $6.8B equity value and $8.5B enterprise value say Berkshire views TMHC as a durable cash generator in a tough housing market. The added color that Taylor Morrison is a Great Place To Work for the second straight year only reinforces that this is a steady operator, not a fixer‑upper.
Conclusion
For active traders, TMHC just graduated from the standard watchlist to the “study this” folder. The price action around $71–$72 is exactly what you want to see when a clean, all‑cash deal at $72.50 hits the tape. Taylor Morrison Home Corporation is now a merger-arb instrument, not a typical trend or breakout play. Range compression on the intraday chart reflects that new reality.
Going forward, every headline about shareholder votes, regulatory reviews, or closing timing in 2H 2026 matters more than quarterly noise. If TMHC trades at a discount to $72.50, the spread reflects perceived risk. If it trades above, the market is sniffing out a higher bid or an improved offer. Either way, this is about odds and catalysts, not hope.
The Berkshire premium also gives traders a reference point for how the market may be underpricing quality names before a catalyst hits. TMHC’s fundamentals — strong margins, solid returns, and a recognized workplace culture — helped attract a deep‑pocketed buyer. That is worth remembering the next time a homebuilder looks “cheap.” As Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” That perspective keeps traders from forcing marginal plays when the spread isn’t right or the risk/reward has shifted.
As Tim Sykes always reminds his community, “The market rewards preparation, not predictions — study every big move so you’re ready for the next one.” TMHC’s takeout by Berkshire Hathaway is one of those big moves. Learn the pattern now, so when the next Taylor Morrison‑style deal hits, you are not chasing the gap after the real opportunity has already flashed by.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.